(lp0
S'Maxim Analyst Comments on Cytori Therapeutics Inc Following Azaya Acquisition Smarter Analyst - Jan 19, 2017 Maxim analyst Jason Kolbert reiterated a Buy rating on shares of Cytori Therapeutics Inc  with a price target of $6.00, after the drug developer announced the acquisitions of Azaya Therapeutics for its proprietary liposomal nanoparticle&nbsp;...Cytori Therapeutics stock surges 7.9% on agreement to buy assets from Azaya ... - MarketWatchCytori Therapeutics  to Acquire Assets from Privately Held Azaya ... - StreetInsider.com'
p1
aS'Correcting The Facts On Cytori Therapeutics Seeking Alpha - Apr 14, 2015 On April 8th, 2015, TheStreet.com published an article by Adam Feuerstein on Cytori Therapeutics . The article was notable for its vindictiveness as it skewered the company for a Benzinga article that included an interview with Cytori CEO,&nbsp;...'
p2
aS"Cytori Therapeutics'  CEO Marc Hedrick on Q1 2016 Results - Earnings ... Seeking Alpha - May 11, 2016 Second, management feels that the combination of the forecasted spend and revenue may be sufficient to get the Company to the point of breakeven by 2018.Stock Update : Cytori Therapeutics Inc Granted Broad European ... - Smarter Analyst"
p3
aS'Stock Update : Cytori Therapeutics Inc Partner Kerastem Completes ... Smarter Analyst - Sep 26, 2016 Cytori Therapeutics Inc  announced that its licensee Kerastem Technologies, LLC, has completed enrollment of STYLE, a US phase II clinical trial investigating early stage female and male pattern hair loss.'
p4
aS'Stock Update : Cytori Therapeutics Inc Announces Increase of ... Smarter Analyst - Sep 19, 2016 Cytori Therapeutics Inc  announced that the Company and Biomedical Advanced Research and Development Authority , a division of the U.S.'
p5
aS'BRIEF-Azaya Therapeutics Reports 5 pct passive stake in Cytori Therapeutics Reuters - Feb 24, 2017 Feb 24 Cytori Therapeutics Inc: * Azaya Therapeutics Inc reports 5 percent passive stake in Cytori Therapeutics as on Feb. 15, 2017 Source text:(bit.'
p6
aS'Reasons I Abandoned My Long Position In Cytori Seeking Alpha  - Aug 19, 2014 I am a physician  and part-time investor. I invest in several biotech companies and was invested in Cytori Therapeutics  for over a year until recently. I look for ...'
p7
aS'The Cytori Therapeutics Inc  Given a $10.00 Price Target by Maxim Group ... Petro Global News 24 - 21 hours ago Cytori Therapeutics Inc  has been assigned a $10.00 price target by analysts at Maxim Group in a report issued on Saturday.Are There Any Catalysts to Propel Shares of Cytori Therapeutics, Inc. (NASDAQ ... - Morgan Research'
p8
aS"BARDA Increases Cytori Therapeutics' Contract Option  Investopedia - Sep 23, 2016 recently announced that the Biomedical Advanced Research and Development Authority , a division of the U.S. Department of Health and Human Services , has increased the valuation of an existing option contract related to the company's&nbsp;..."
p9
aS'Cytori Provides Latest Corporate Update at the 2nd Annual Disruptive Growth ... GlobeNewswire  - Feb 14, 2017 SAN DIEGO, Feb. 14, 2017  -- Cytori Therapeutics, Inc.  announced today that it will present at the 2nd Annual Disruptive Growth &amp; Healthcare Conference at 11:15 AM Eastern Time  on&nbsp;...'
p10
a.